Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir vs NPH in Pregnant Women
NCT05124457Phase 2Recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Feb 2022
- Primary completion
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of insulin detemir in gestational diabetes mellitus (GDM), type 2 diabetes mellitus (T2DM), sponsored by University of California, Los Angeles. Started Feb 2022; status: recruiting.
02
Drugs
insulin detemir
03
Conditions
gestational diabetes mellitus (GDM)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05124457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05124457.